O

OrbiMed Portfolio holdings

AUM $3.98B
This Quarter Return
+15.41%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.46B
AUM Growth
+$5.46B
Cap. Flow
-$50.4M
Cap. Flow %
-0.92%
Top 10 Hldgs %
41.94%
Holding
129
New
17
Increased
19
Reduced
31
Closed
16

Top Buys

1
MBX
MBX Biosciences, Inc. Common Stock
MBX
$99M
2
UNH icon
UnitedHealth
UNH
$39.2M
3
SRPT icon
Sarepta Therapeutics
SRPT
$38.5M
4
AMGN icon
Amgen
AMGN
$37.8M
5
UHS icon
Universal Health Services
UHS
$35.7M

Top Sells

1
JANX icon
Janux Therapeutics
JANX
$78.2M
2
THC icon
Tenet Healthcare
THC
$65M
3
PCVX icon
Vaxcyte
PCVX
$46.7M
4
VRNA
Verona Pharma
VRNA
$41.4M
5
GERN icon
Geron
GERN
$37.9M

Sector Composition

1 Healthcare 99.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PHGE icon
101
BiomX
PHGE
$14.1M
$1.82M 0.03%
1,787,767
-11,985,886
-87% +$419K
IVVD icon
102
Invivyd
IVVD
$218M
$1.76M 0.03%
1,728,300
-697,500
-29% -$711K
TSBX
103
DELISTED
Turnstone Biologics
TSBX
$1.73M 0.03%
3,099,265
– –
NXTC icon
104
NextCure
NXTC
$13.3M
$1.56M 0.03%
1,141,200
– –
VIGL
105
DELISTED
Vigil Neuroscience
VIGL
$1.53M 0.03%
448,891
– –
KZR icon
106
Kezar Life Sciences
KZR
$28.5M
$1.49M 0.03%
1,927,000
– –
ELEV
107
DELISTED
Elevation Oncology
ELEV
$565K 0.01%
941,275
– –
XERS icon
108
Xeris Biopharma Holdings
XERS
$1.27B
$229K ﹤0.01%
80,420
– –
OMIC
109
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
– –
-18,023
Closed -$152K
MORF
110
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-612,500
Closed -$20.9M
SOLV icon
111
Solventum
SOLV
$12.4B
– –
0
– –
VRNA
112
Verona Pharma
VRNA
$9.18B
– –
-2,861,801
Closed -$41.4M
TGTX icon
113
TG Therapeutics
TGTX
$5.03B
– –
-133,200
Closed -$2.37M
SAVA icon
114
Cassava Sciences
SAVA
$107M
– –
0
– –
PGNY icon
115
Progyny
PGNY
$2.02B
– –
-259,900
Closed -$7.44M
PFE icon
116
Pfizer
PFE
$141B
– –
0
– –
ORIC icon
117
Oric Pharmaceuticals
ORIC
$1.03B
– –
-287,100
Closed -$2.03M
MRUS icon
118
Merus
MRUS
$5.04B
– –
-156,100
Closed -$9.24M
MRNA icon
119
Moderna
MRNA
$9.36B
– –
0
– –
HRTX icon
120
Heron Therapeutics
HRTX
$204M
– –
-6,512,866
Closed -$22.8M
GERN icon
121
Geron
GERN
$893M
– –
-8,930,252
Closed -$37.9M
DXCM icon
122
DexCom
DXCM
$30.9B
– –
-289,900
Closed -$32.9M
DVAX icon
123
Dynavax Technologies
DVAX
$1.19B
– –
-113,500
Closed -$1.27M
CATX icon
124
Perspective Therapeutics
CATX
$251M
– –
-492,670
Closed -$4.91M
BMRN icon
125
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
-26,100
Closed -$2.15M
2 3 4
5
6